-
Je něco špatně v tomto záznamu ?
Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries
FG. Rebitschek, N. Pashayan, M. Widschwendter, O. Wegwarth,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
Department of Health - United Kingdom
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
Public Library of Science (PLoS)
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-12-01
Open Access Digital Library
od 2006-10-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-12-01
Health & Medicine (ProQuest)
od 2006-12-01
Public Health Database (ProQuest)
od 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
- MeSH
- chování snižující riziko MeSH
- dospělí MeSH
- genetická predispozice k nemoci * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mastektomie psychologie MeSH
- nádory prsu genetika patologie psychologie chirurgie MeSH
- prognóza MeSH
- průzkumy a dotazníky MeSH
- riziko MeSH
- rozhodování * MeSH
- senioři MeSH
- úmysl * MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
- Itálie MeSH
- Německo MeSH
- Spojené království MeSH
- Švédsko MeSH
BACKGROUND: Personal cancer risk assessments enable stratified care, for example, offering preventive surgical measures such as risk-reducing mastectomy (RRM) to women at high risk for breast cancer. In scenario-based experiments, we investigated whether different benefit-harm ratios of RRM influence women's consideration of this, whether this consideration is influenced by women's perception of and desire to know their personal cancer risk, or by their intention to take a novel cancer risk-predictive test, and whether consideration varies across different countries. METHOD: In January 2017, 1,675 women 40 to 75 years of age from five European countries-Czech Republic, Germany, UK, Italy, and Sweden-took part in an online scenario-based experiment. Six different scenarios of hypothetical benefit-harm ratios of RRM were presented in accessible fact box formats: Baseline risk/risk reduction pairings were 20/16, 20/4, 10/8, 10/2, 5/4, and 5/1 out of 1,000 women dying from breast cancer. RESULTS: Varying the baseline risk of dying from breast cancer and the extent of risk reduction influenced the decision to consider RRM for 23% of women. Decisions varied by country, risk perception, and the intention to take a cancer risk-predictive test. Women who expressed a stronger intention to take such a test were more likely to consider having RRM. The desire to know one's risk of developing any female cancer in general moderated women's decisions, whereas the specific desire to know the risk of breast cancer did not. CONCLUSIONS: In this hypothetical scenario-based study, only for a minority of women did the change in benefit-harm ratio inform their consideration of RRM. Because this consideration is influenced by risk perception and the intention to learn one's cancer risks via a cancer risk-predictive test, careful disclosure of different potential preventive measures and their benefit-harm ratios is necessary before testing for individual risk. Furthermore, information on risk testing should acknowledge country-specific sensitivities for benefit-harm ratios.
Department of Applied Health Research University College London London United Kingdom
Department of Women's Cancer University College London London United Kingdom
Harding Center for Risk Literacy Max Planck Institute for Human Development Berlin Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20015874
- 003
- CZ-PrNML
- 005
- 20201119104858.0
- 007
- ta
- 008
- 201012s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0218188 $2 doi
- 035 __
- $a (PubMed)31188874
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Rebitschek, Felix G $u Harding Center for Risk Literacy, Max Planck Institute for Human Development, Berlin, Germany.
- 245 10
- $a Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries / $c FG. Rebitschek, N. Pashayan, M. Widschwendter, O. Wegwarth,
- 520 9_
- $a BACKGROUND: Personal cancer risk assessments enable stratified care, for example, offering preventive surgical measures such as risk-reducing mastectomy (RRM) to women at high risk for breast cancer. In scenario-based experiments, we investigated whether different benefit-harm ratios of RRM influence women's consideration of this, whether this consideration is influenced by women's perception of and desire to know their personal cancer risk, or by their intention to take a novel cancer risk-predictive test, and whether consideration varies across different countries. METHOD: In January 2017, 1,675 women 40 to 75 years of age from five European countries-Czech Republic, Germany, UK, Italy, and Sweden-took part in an online scenario-based experiment. Six different scenarios of hypothetical benefit-harm ratios of RRM were presented in accessible fact box formats: Baseline risk/risk reduction pairings were 20/16, 20/4, 10/8, 10/2, 5/4, and 5/1 out of 1,000 women dying from breast cancer. RESULTS: Varying the baseline risk of dying from breast cancer and the extent of risk reduction influenced the decision to consider RRM for 23% of women. Decisions varied by country, risk perception, and the intention to take a cancer risk-predictive test. Women who expressed a stronger intention to take such a test were more likely to consider having RRM. The desire to know one's risk of developing any female cancer in general moderated women's decisions, whereas the specific desire to know the risk of breast cancer did not. CONCLUSIONS: In this hypothetical scenario-based study, only for a minority of women did the change in benefit-harm ratio inform their consideration of RRM. Because this consideration is influenced by risk perception and the intention to learn one's cancer risks via a cancer risk-predictive test, careful disclosure of different potential preventive measures and their benefit-harm ratios is necessary before testing for individual risk. Furthermore, information on risk testing should acknowledge country-specific sensitivities for benefit-harm ratios.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a nádory prsu $x genetika $x patologie $x psychologie $x chirurgie $7 D001943
- 650 12
- $a rozhodování $7 D003657
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a úmysl $7 D033182
- 650 _2
- $a mastektomie $x psychologie $7 D008408
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a riziko $7 D012306
- 650 _2
- $a chování snižující riziko $7 D040242
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 651 _2
- $a Česká republika $7 D018153
- 651 _2
- $a Německo $7 D005858
- 651 _2
- $a Itálie $7 D007558
- 651 _2
- $a Švédsko $7 D013548
- 651 _2
- $a Spojené království $7 D006113
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pashayan, Nora $u Department of Applied Health Research, University College London, London, United Kingdom.
- 700 1_
- $a Widschwendter, Martin $u Department of Women's Cancer, University College London, London, United Kingdom.
- 700 1_
- $a Wegwarth, Odette $u Harding Center for Risk Literacy, Max Planck Institute for Human Development, Berlin, Germany. Center for Adaptive Rationality, Max Planck Institute for Human Development, Berlin, Germany.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 14, č. 6 (2019), s. e0218188
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31188874 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201012 $b ABA008
- 991 __
- $a 20201119104855 $b ABA008
- 999 __
- $a ok $b bmc $g 1584301 $s 1106042
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 14 $c 6 $d e0218188 $e 20190612 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- GRA __
- $p Department of Health $2 United Kingdom
- LZP __
- $a Pubmed-20201012